ImmTher lipophilic disaccharide peptide: Will begin Phase II trial

ImmunoTherapeutics Inc. (IMNP) Product: ImmTher lipophilic disaccharide peptide, an immunodulator Indication: Colorectal cancer Status: Will begin Phase II trial in patients not previously treated wit...